Details for New Drug Application (NDA): 211011
✉ Email this page to a colleague
The generic ingredient in CARMUSTINE is carmustine. There are eleven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the carmustine profile page.
Summary for 211011
Tradename: | CARMUSTINE |
Applicant: | Ingenus Pharms Llc |
Ingredient: | carmustine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 211011
Suppliers and Packaging for NDA: 211011
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CARMUSTINE | carmustine | INJECTABLE;INJECTION | 211011 | ANDA | Athenex Pharmaceutical Division, LLC | 70860-223 | 70860-223-61 | 1 KIT in 1 CARTON (70860-223-61) * 30 mL in 1 VIAL, SINGLE-DOSE (70860-221-30) * 3 mL in 1 VIAL (70860-222-03) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/VIAL | ||||
Approval Date: | Jun 21, 2022 | TE: | RLD: | No |
Complete Access Available with Subscription